Each filer's latest filing for 282559103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Vanguard Group Inc 13G | 5.6% |
7/29/2025
Event 6/30/2025
|
||
|
Suvretta Capital Management, LLC
13G/A
|
5.6% |
11/13/2025
Event 9/30/2025
|
||
| Suvretta Capital Management, LLC | 5.6% | |||
| Averill Master Fund, Ltd. | 4.8% | |||
| Aaron Cowen | 5.6% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (7) | ||||
| Janus Henderson Group PLC 13G/A | 3.6% |
10/7/2025
Event 9/30/2025
|
||
|
Biotechnology Value Fund L P
13G/A
|
3.6% |
2/14/2025
Event 12/31/2024
|
||
| Biotechnology Value Fund L P | 1.9% | |||
| BVF I GP LLC | 1.9% | |||
| Biotechnology Value Fund II LP | 1.5% | |||
| BVF II GP LLC | 1.5% | |||
| Biotechnology Value Trading Fund OS LP | 0.2% | |||
| BVF Partners OS Ltd. | 0.2% | |||
| BVF GP Holdings LLC | 3.4% | |||
| BVF Partners L P/IL | 3.6% | |||
| BVF Inc/IL | 3.6% | |||
| Lampert Mark N | 3.6% | |||
|
RTW Investments, LP
13G/A
|
1.3% |
5/15/2025
Event 3/31/2025
|
||
| RTW Investments, LP | 1.3% | |||
| Roderick Wong, M.D. | 1.3% | |||
|
Adage Capital Management, L.P.
13D/A
|
0% |
10/31/2025
Event 10/29/2025
|
||
| Adage Capital Management, L.P. | 0% | |||
| Robert Atchinson | 0% | |||
| Phillip Gross | 0% | |||
|
Deep Track Capital, LP
13G/A
|
0% |
2/13/2026
Event 12/31/2025
|
||
| Deep Track Capital, LP | 0% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 0% | |||
| David Kroin | 0% | |||
|
Pentwater Capital Management LP
13G
|
0% |
11/14/2025
Event 9/30/2025
|
||
| Pentwater Capital Management LP | 0% | |||
| Matthew Halbower | 0% | |||
|
RA Capital Management, L.P.
13D/A
|
0% |
11/3/2025
Event 10/30/2025
|
||
| RA Capital Management, L.P. | 0% | |||
| Peter Kolchinsky | 0% | |||
| Rajeev Shah | 0% | |||
| RA Capital Healthcare Fund, L.P. | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q4 | 2 | 90.0 k | $1.11M |
| 2025 Q3 | 204 | 155 M | $2.27B |
| 2025 Q2 | 192 | 161 M | $1.58B |
| 2025 Q1 | 192 | 154 M | $1.14B |
| 2024 Q4 | 159 | 121 M | $947M |
| 2024 Q3 | 147 | 105 M | $774M |
| 2024 Q2 | 148 | 103 M | $828M |
| 2024 Q1 | 155 | 98.4 M | $1.14B |
| 2023 Q4 | 156 | 94.2 M | $1.05B |
| 2023 Q3 | 171 | 72.0 M | $1.11B |
| 2023 Q2 | 159 | 77.2 M | $1.46B |
| 2023 Q1 | 152 | 71.0 M | $1.08B |
| 2022 Q4 | 109 | 46.4 M | $591M |
| 2022 Q3 | 88 | 39.3 M | $227M |
| 2022 Q2 | 71 | 32.5 M | $105M |
| 2022 Q1 | 70 | 17.1 M | $64.3M |
| 2021 Q4 | 52 | 17.3 M | $226M |
| 2021 Q3 | 50 | 17.3 M | $339M |
| 2021 Q2 | 51 | 16.9 M | $315M |
| 2021 Q1 | 68 | 16.9 M | $401M |
| 2020 Q4 | 70 | 16.7 M | $407M |
| 2020 Q3 | 69 | 16.0 M | $411M |
| 2020 Q2 | 39 | 10.6 M | $215M |
| 2020 Q1 | 31 | 10.7 M | $270M |
| 2019 Q4 | 35 | 10.4 M | $275M |